Article (Scientific journals)
Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives.
Wegner, Ilse; Edelbroek, Peter M.; BULK, Saskia et al.
2009In Neurology, 73 (17), p. 1388-93
Peer Reviewed verified by ORBi
 

Files


Full Text
Bulk 18.pdf
Publisher postprint (526.13 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Adolescent; Adult; Anticonvulsants/blood/pharmacokinetics; Contraceptives, Oral/pharmacology; Drug Interactions; Epilepsy/blood/drug therapy/physiopathology; Female; Humans; Kinetics; Menopause/blood/physiology; Menstrual Cycle/blood/physiology; Middle Aged; Prospective Studies; Time Factors; Triazines/blood/pharmacokinetics; Young Adult
Abstract :
[en] OBJECTIVE: We prospectively evaluated the fluctuation of lamotrigine (LTG) clearance during the menstrual cycle. We also assessed the effect of postmenopausal status and investigated in detail the effect of oral contraceptives (OCs) on LTG clearance. METHODS: Three groups of women with epilepsy using LTG monotherapy were evaluated. Women in the first group (n = 7) had a regular cycle and did not use OCs; the second group used a 1-phase combined OC (n = 7), and the third group (n = 7) was postmenopausal. Two menstrual cycles or at least 2 months (postmenopausal women) were assessed, monitoring LTG levels every other day. RESULTS: The mean apparent LTG clearance in women of reproductive age not using OCs was 49 (SD 22.6, range 20.4-83.5) L/24 hours. No significant effect of endogenous hormones on LTG clearance was found. In women using OCs, the mean LTG clearance was 126 (SD 60.2, range 44.3-205) L/24 hours. There was an increase in LTG levels during the pill-free week, with maximum levels 54% (range 29%-129%) higher than baseline levels. LTG levels decreased to the baseline value within a mean of 8 days of starting OC use (SD 3.7, range 2.5-16.5). In the postmenopausal women, the mean clearance was 82 (SD 38.4, range 35.9-125) L/24 hours. CONCLUSIONS: We observed a higher mean lamotrigine (LTG) clearance in postmenopausal women compared with young women not using oral contraceptives (OCs) and confirmed that OC use may have a strong effect on LTG clearance. There was no significant fluctuation of LTG clearance during the menstrual cycle.
Disciplines :
Genetics & genetic processes
Author, co-author :
Wegner, Ilse
Edelbroek, Peter M.
BULK, Saskia ;  Centre Hospitalier Universitaire de Liège - CHU > Génétique
Lindhout, Dick
Language :
English
Title :
Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives.
Publication date :
2009
Journal title :
Neurology
ISSN :
0028-3878
eISSN :
1526-632X
Publisher :
Lippincott Williams & Wilkins, United States - Maryland
Volume :
73
Issue :
17
Pages :
1388-93
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 23 May 2015

Statistics


Number of views
60 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
40
Scopus citations®
without self-citations
37
OpenCitations
 
38

Bibliography


Similar publications



Contact ORBi